- Home
- FLEX vs ILMN Comparison
FLEX vs ILMN Comparison
Compare FLEX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLEX
- ILMN
- Stock Information
- Founded
- FLEX 1990
- ILMN 1998
- Country
- FLEX United States
- ILMN United States
- Employees
- FLEX N/A
- ILMN N/A
- Industry
- FLEX Electrical Products
- ILMN Medical Specialities
- Sector
- FLEX Technology
- ILMN Health Care
- Exchange
- FLEX Nasdaq
- ILMN Nasdaq
- Market Cap
- FLEX 18.7B
- ILMN 16.9B
- IPO Year
- FLEX 1994
- ILMN 2000
- Fundamental
- Price
- FLEX $49.00
- ILMN $100.11
- Analyst Decision
- FLEX Strong Buy
- ILMN Buy
- Analyst Count
- FLEX 9
- ILMN 17
- Target Price
- FLEX $52.00
- ILMN $127.00
- AVG Volume (30 Days)
- FLEX 4.3M
- ILMN 2.2M
- Earning Date
- FLEX 07-24-2025
- ILMN 07-31-2025
- Dividend Yield
- FLEX N/A
- ILMN N/A
- EPS Growth
- FLEX 2.29
- ILMN N/A
- EPS
- FLEX 2.28
- ILMN 7.91
- Revenue
- FLEX $26,074,000,000.00
- ILMN $4,284,000,000.00
- Revenue This Year
- FLEX $4.81
- ILMN N/A
- Revenue Next Year
- FLEX $4.36
- ILMN $2.78
- P/E Ratio
- FLEX $21.49
- ILMN $12.66
- Revenue Growth
- FLEX 0.92
- ILMN N/A
- 52 Week Low
- FLEX $25.11
- ILMN $68.70
- 52 Week High
- FLEX $53.97
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- FLEX 44.68
- ILMN 53.08
- Support Level
- FLEX $49.02
- ILMN $93.32
- Resistance Level
- FLEX $52.37
- ILMN $101.37
- Average True Range (ATR)
- FLEX 1.50
- ILMN 3.55
- MACD
- FLEX -0.32
- ILMN -0.38
- Stochastic Oscillator
- FLEX 17.94
- ILMN 45.08
About FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.